Do inhaled steroids reduce bone mineral density and increase fracture risk?
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
Inhaled corticosteroids (ICS) at low to medium doses (<1500 mcg beclomethasone hydrofluoroalkane per day) for asthma and chronic obstructive pulmonary disease (COPD) don't increase the risk of significant bone loss or fracture at 2 to 3 years follow-up (strength of recommendation [SOR]: A, systematic reviews and randomize controlled trials [RCTs]). Higher doses, however, may raise the risk of nontraumatic fracture over 1 to 4 years of follow-up (SOR: B, case control studies). Experts recommend using the lowest effective dose to mitigate potential bone risks (SOR: C, expert consensus).
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.